As early as the 2nd century, Galen proposed that ‘vital spirits’ in the blood regulated human bodily functions. However, the concept of hormonal activity required a further 18 centuries to develop and relied upon the identification of ‘ductless glands’, Schwann’s cell and the recognition by Bayliss and Starling of chemical messengers. Bernard’s introduction of ‘internal secretion’ and its role in homeostasis laid a physiological basis for the development of endocrinology. Kocher and Addison recognized the consequences of ablation of glands by disease or surgery and identified their necessary role in life. Detailed descriptions of the endocrine cells of the gut and pancreas and their putative function were provided by Heidenhain, Langerhans, Laguesse and Sharpey-Schäfer. Despite the dominant 19th century concept of nervism (Pavlov), in 1902, Starling and Bayliss using Hardy’s term ‘hormonos’ described secretin and in so doing, established the gut as an endocrine organ. Thus, nervism was supplanted by hormonal regulation of function and thereafter numerous bioactive gut peptides and amines were identified. At virtually the same time (1892), Ramón y Cajal of Madrid reported the existence of a group of specialized intestinal cells that he referred to as ‘interstitial cells’. Cajal postulated that they might function as an interface between the neural system and the smooth muscles of the gut. Some 22 years later, Keith suggested that their function might be analogous to the electroconductive system of the heart and proposed their role as components of an intestinal pacemaker system. This prescient hypothesis was subsequently confirmed in 1982 by Thuneberg and a decade later Maede identified c-Kit as a critical molecular regulator in the development and function of the interstitial cells of Cajal and further confirmed the commonality of neural and endocrine cells. The additional characterization of the endocrine regulatory system of the GI tract was implemented when Feyrter (1938) using Masson’s staining techniques, identified ‘helle Zellen’ within the pancreatic ductal system and the intestinal epithelium and proposed the concept of a diffuse neuroendocrine system. Pearse subsequently grouped the various cells belonging to that system under the rubric of a unifying APUD series. Currently, the gut neuroendocrine system is viewed as a syncytium of neural and endocrine cells sharing a common cell lineage whose phenotypic regulation is as yet unclear. Their key role in the regulation of gastrointestinal function is, however, indubitable.

Keywords:
‘APUD’, Clear cells, Feyrter, Pearse, Neuroendocrine, Cajal, Carcinoid
1.
Mettler CC: History of Medicine. Philadelphia, Blakiston, 1947.
2.
Needham J: Proto-Endocrinology in Medieval China. Cambridge, Cambridge University Press, 1966.
3.
Himes NE: A Medical History of Contraception. New York, Gamut Press, 1936.
4.
Harris GW: Humours and hormones. J Endocrinol 1972;53:2–23.
5.
Vesalius A: De humani corporis fabrica librii septem. Basel, Oporinus, 1543.
6.
Wharton T: Adenographia sive glandularum totius corporis description. London, Coll. Lond. Socii Amstelaedami, 1659.
7.
Modlin IM, Kidd M: The Paradox of the Pancreas: from Wirsung to Whipple. Hanover, Politzki Print Productions, 2003.
8.
Haller AV: Elementa physiologiae corporis humani. Lausanne, 1757–1766.
9.
Sharpey-Schafer E: Endocrine physiology. Irish J Med Sci 1931;69:483–505.
10.
Schleiden MJ: Beiträge zur Phytogenesis. Arch Anat Physiol 1838, pp 137–176.
11.
Hughes A: A History of Cytology. London, Abelard-Schuman, 1959.
12.
Schwann T: Ueber das Wesen des Verdauungsprocesses. Arch Anat Physiol 1836:90–138.
13.
Schwann T: Mikroskopische Untersuchungen über İbereinstimmung in der Struktur und dem Wachsthum der Thiere und Pflanzen. Berlin, Verlag der Sanderschen Buchhandlung, 1839.
14.
Virchow R: Die Cellularpathologie, ed 4. Berlin, Hirschwald, 1871.
15.
Bernard C: Sur une nouvelle fonction du foie chez l’homme et les animaux. CR Acad Sci 1850;31:571–574.
16.
Hunter J: Observations on Certain Parts of the Animal Oeconomy. London, 1786.
17.
Addison T: On the Constitution and Local Effects of Diseases of the Supra Renal Capsules. London, Samuel Highley, 1855.
18.
Brown-Séquard CE: Recherches expérimentales sur la physiologie et la pathologie des capsules surrénales. CR Acad Sci 1856;43:422–425.
19.
Oliver G, Schaefer EA: On the physiological action of extract of the suprarenal capsules. J Physiol 1894;17:i–v.
20.
Kocher T: Concerning pathological manifestations in low-grade thyroid diseases. Nobel-Lecture, 1909.
21.
Heidenhain RP: Untersuchungen über den Bau der Labdrüsen. Arch Mikr Anat 1870;6:368–406.
22.
Langerhans P: Beiträge zur mikroskopischen Anatomie der Bauchspeicheldrüse. Berlin, 1869.
23.
Laguesse GE: Sur la formation des Ilots de Langerhans dans le pancréas. CR Soc Biol 1893;5:819–820.
24.
Kulchitsky N: Zur Frage über den Bau des Darmkanals. Arch Mikr Anat 1897;49:7–35.
25.
Pavlov IP: Die Innervation des Pankreas. Klin Wochenzeitung 1888;32:667–675.
26.
Pavlov IP: Lektsii o rabote glavnykh pischchevaritel’nykh zhelez (The work of the digestive glands). St. Petersburg, Piroda, 1897.
27.
Bayliss WM, Starling EH: The mechanism of pancreatic secretion. J Physiol 1902;28:325–353.
28.
Martin C: Ernest Henry Starling (obituary). Br Med J 1927;i:900–906.
29.
Starling EH: The Croonian Lectures on the chemical correlation of the functions of the body. Lancet 1905;166:339–341.
30.
Garrison FH: History of Medicine, ed 4, Philadelphia, Saunders, 1929.
31.
David K: İber krystallinisches männliches Hormon aus Hoden (Testosteron) wirksamer als aus Harn oder aus Cholesterin bereitetes Androsteron. Z Physiol Chem 1935;233:281.
32.
Collip JB: The extraction of a parathyroid hormone which will prevent or control parathyroid tetany and which regulates the level of blood calcium. J Biol Chem 1925;63:395–438.
33.
Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932;50:137–195.
34.
Kendall EC: A method for the decomposition of the proteins of the thyroid, with a description of certain constituents. J Biol Chem 1915;20:501–509.
35.
Banting FG: The internal secretion of the pancreas. J Lab Clin Med 1922;7:253.
36.
Medvei VC: The History of Clinical Endocrinology, ed 2. New York, Parthenon, 1993.
37.
Ramón y Cajal S: Nuevas aplicationes del método de coloración de Golgi. Gaceta Médica Catalana 1889;12:613–616.
38.
Ramón y Cajal S: Sur les ganglions et plexus nerveux de l’intestin. CR Soc Biol 1893;45:217–223.
39.
The Nobel Prize Winners – Physiology or Medicine. Pasadena, Salem Press, 1991.
40.
Golgi C: On the structure of the brain grey matter. Gaz Med Ital, 1873.
41.
Ramón y Cajal S: Histologie du système nerveux de l’homme et des vertébrés. Grand sympathique. Paris, Maloine, 1911, vol 2, pp 891–942.
42.
Keith A: An account of six specimens of the great bowel removed by operation: with some observations on the motor mechanism of the colon. Br J Surg 1914;2:576–599.
43.
Keith A: A new theory of the causation of enterostasis. Lancet 1915;ii:371–375.
44.
Thuneberg L: One hundred years of interstitial cells of Cajal. Microsc Res Tech 1999;47:223–238.
45.
Lawrentjew BI: İber die nervöse Natur und das Vorkommen der sogenannten interstitiellen Zellen (Cajal, Dogiel) in der glatten Muskulatur. Proc Kon Acad Wetensch 1925;28:977–983.
46.
Feyrter F: Standardization of silver impregnation of neural and non-neural tissues. Virchows Arch 1951;320:551–563.
47.
Meyling HA: Structure and significance of the peripheral extension of the autonomic nervous system. J Comp Neurol 1953;99:495–543.
48.
Jabonero V: Plexiform synapse of distance and significance of so-called intercalated cells. Acta Neuroveg (Wien) 1959;19:276–302.
49.
Taxi J: Contribution á l’étude des connexions des neurones moteurs du système nerveux autonome. Ann Sci Nat Zool 1965;7:413–674.
50.
Taxi J: Sur la structure des travées du plexus d’Auerbach: Confrontation des données fournies par le microscope ordinaire et par le microscope électronique. Ann Sci Nat Zool 1959;1:571–593.
51.
Taxi J: Cellules de Schwann et ‘cellules interstitielles de Cajal’ au niveau des plexus nerveuz de la musculeuse intestinale du cobaye: retour aux définitions. Arch Anat Microsc 1952;41:281–304.
52.
Tinel J: Le Systéme Nerveux Végétatif. Paris, Libr l’Acad Méd, 1937.
53.
Imaizumi M, Hama K: An electron microscopic study on the interstitial cells of the gizzard in the love-bird (Uroloncha domestica). Z Zellforsch Mikrosk Anat 1969;97:351–357.
54.
Yamamoto M: Electron microscopic studies on the innervation of the smooth muscle and the interstitial cell of Cajal in the small intestine of the mouse and bat. Arch Histol Jpn 1977;40:171–201.
55.
Daniel EE: Nerves and motor activity of the gut; in Brooks FPE (ed): Nerves and the Gut. New York, Slack, 1977, pp 154–196.
56.
Ambache N: The electrical activity of isolated mammalian intestines. J Physiol 1947;106:139–153.
57.
Thuneberg L: Interstitial cells of Cajal: intestinal pacemaker cells? Adv Anat Embryol Cell Biol 1982;71:1–130.
58.
Stach W: The extreme enteric plexus of the large intestine and its relation to the interstitial cells (Cajal). Z Mikrosk Anat Forsch 1972;85:245–272.
59.
Barajas-Lopez C, Berezin I, Daniel EE, Huizinga JD: Pacemaker activity recorded in interstitial cells of Cajal of the gastrointestinal tract. Am J Physiol 1989;257:C830–C835.
60.
Lee JC, Thuneberg L, Berezin I, Huizinga JD: Generation of slow waves in membrane potential is an intrinsic property of interstitial cells of Cajal. Am J Physiol 1999;277:G409–G423.
61.
Faussone-Pellegrini MS: Histogenesis, structure and relationships of interstitial cells of Cajal (ICC): from morphology to functional interpretation. Eur J Morphol 1992;30:137–148.
62.
Maeda H, Yamagata A, Nishikawa S, Yoshinaga K, Kobayashi S, Nishi K, Nishikawa S: Requirement of c-kit for development of intestinal pacemaker system. Development 1992;116:369–375.
63.
Ward SM, Burns AJ, Torihashi S, Sanders KM: Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine. J Physiol 1994;480:91–97.
64.
Huizinga JD, Thuneberg L, Kluppel M, Malysz J, Mikkelsen HB, Bernstein A: W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 1995;373:347–349.
65.
Romert P, Mikkelsen HB: c-kit immunoreactive interstitial cells of Cajal in the human small and large intestine. Histochem Cell Biol 1998;109:195–202.
66.
Lecoin L, Gabella G, Le Douarin N: Origin of the c-kit-positive interstitial cells in the avian bowel. Development 1996;122:725–733.
67.
Kluppel M, Huizinga JD, Malysz J, Bernstein A: Developmental origin and Kit-dependent development of the interstitial cells of Cajal in the mammalian small intestine. Dev Dyn 1998;211:60–71.
68.
Torihashi S, Ward S, Sanders K: Development of c-Kit-positive cells and the onset of electrical rhythmicity in murine small intestine. Gastroenterology 1997;112:144–155.
69.
Torihashi S, Nishi K, Tokutomi Y, Nishi T, Ward S, Sanders K: Blockade of kit signaling induces transdifferentiation of interstitial cells of Cajal to a smooth muscle phenotype. Gastroenterology 1999;117:140–148.
70.
Burns AJ, Lomax AE, Torihashi S, Sanders KM, Ward SM: Interstitial cells of Cajal mediate inhibitory neurotransmission in the stomach. Proc Natl Acad Sci USA 1996;93:12008–12013.
71.
Ward SM, Morris G, Reese L, Wang XY, Sanders KM: Interstitial cells of Cajal mediate enteric inhibitory neurotransmission in the lower esophageal and pyloric sphincters. Gastroenterology 1998;115:314–329.
72.
Schiefferdecker P: İber die Neuronen und die innere Sekretion. Sitzgsber Niedderrhein Ges Naturheilkd 1905, pp 46–54.
73.
Tigerstedt RA: Niere und Kreislauf. Scand Arch Physiol 1898;8:223–271.
74.
Cannon WB: The emergency function of the adrenal medulla in pain and the major emotions. Am J Physiol 1914;33:356–372.
75.
Elliott TR: The innervation of the bladder and urethra. J Physiol 1907;35:367–445.
76.
Loewi O: İber humorale İbertragbarkeit der Herznervenwirkung. Pflügers Arch ges Physiol 1921;189:239–242.
77.
Nicolas A: Recherches sur l’épithélium de l’intestine grele. Int Mschr Anat Physiol 1891;8:1–8.
78.
Schmidt JE: Beiträge zur normalen und pathologischen Histologie einiger Zellarten der Schleimhaut des menschlichen Darm-Kanals. Arch Mikrosk Anat 1905;66:12–40.
79.
Ciaccio C: Ricerche istologiche e citologiche sul timo degli Uccelli. Anat Anz 1906;29:597–600.
80.
Ciaccio C: Sur une nouvelle espéce cellulaire dans les glandes de Lieberkühn. CR Soc Biol Paris 1906;60:76–77.
81.
Masson P: La glande endocrine de l’intestin chez l’homme. CR Acad Sci 1914;158:59–61.
82.
Gosset A, Masson P: Tumeurs endocrines de l’appendice. Presse Med 1914;25:237–240.
83.
Masson P: Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa. Am J Path 1928;4:181–212.
84.
Erös G: İber die argentaffinen Zellen der Schleimhaut des Magen-Darmtraktes. Frankf Z Pathol 1928;36:402.
85.
Erös G: İber die Bedeutung der argentaffinen Zellen. Frankf Z Pathol 1931;40:155.
86.
Erös G: Eine neue Darstellungsmethode der sogenannten gelben argentaffinen Zellen des Magen-Darmtraktes. Zbl Path 1932;54:385.
87.
Kahlau G: Versuch zur Beeinflussung der gelben Zellen des Darmes durch Hormone. Z Exper Med 1931;80:190.
88.
Feyrter F: İber diffuse endocrine epitheliale Organe. Leipzig, Barth, 1938.
89.
Feyrter F: Karzinoid und Karzinom. Ergebn Allg Pathol Anat 1934;29:305–489.
90.
Hakanson R, Sundler F: APUD cells in rat oxyntic mucosa. Gastroenterology 1979;77:800–803.
91.
Capella C, Polak JM, Timson CM, Frigerio B, Solcia E: Gastric carcinoids of argyrophil ECL cells. Ultrastruct Pathol 1980;1:411–418.
92.
Modlin IM, Kidd M, Pfragner R, Eick GN, Champaneria MC: The functional characterization of normal and neoplastic human enterochromaffin cells. J Clin Endocrinol Metab 2006;91:2340–2348.
93.
Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD: Current status of gastrointestinal carcinoids. Gastroenterology 2005;128:1717–1751.
94.
Masson P: Appendicite neurogene et carcinoides. Ann Anat Path 1924;1:20.
95.
Sunder-Plassmann P: İber neuro-hormonale Zellen des Vagussystem in der Schilddrüse. Dtsch Z Chir 1939;252:210–223.
96.
Altmann HW: Die parafollikuläre Zelle der Schilddrüse und ihre Beziehungen zu der Gelben Zelle des Darmes. Beitr Path Anat 1940;104:419–428.
97.
Pagés A: Essai sur le système des cellules claires de Feyrter. Université de Montpellier, 1955.
98.
Pearse AG: The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 1969;17:303–313.
99.
Pearse AG: Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin. Proc R Soc Lond [B] 1968;170:71–80.
100.
Pearse AG: The diffuse endocrine (paracine) system: Feyrter’s concept and its modern history. Verh Dtsch Ges Pathol 1977;61:2–6.
101.
Day R, Salzet M: The neuroendocrine phenotype, cellular plasticity, and the search for genetic switches: redefining the diffuse neuroendocrine system. Neuro Endocrinol Lett 2002;23:447–451.
102.
Szijj I, Csapo Z, Laszlo FA, Kovacs K: Medullary cancer of the thyroid gland associated with hypercorticism. Cancer 1969;24:167–173.
103.
Welbourn RB: Apudomas of the gut. Am J Surg 1977;133:13–22.
104.
Langley K: The neuroendocrine concept today. Ann NY Acad Sci 1994;733:1–17.
105.
Bishop AE, Polak JM: Cytochemical techniques for studying the diffuse neuroendocrine system. Methods Enzymol 1989;168:791–808.
106.
Bishop AE, Power RF, Polak JM: Markers for neuroendocrine differentiation. Pathol Res Pract 1988;183:119–128.
107.
Pearse AG, Polak JM: Neural crest origin of the endocrine polypeptide (APUD) cells of the gastrointestinal tract and pancreas. Gut 1971;12:783–788.
108.
Pearse AG, Takor T: Embryology of the diffuse neuroendocrine system and its relationship to the common peptides. Fed Proc 1979;38:2288–2294.
109.
Andrew A, Kramer B, Rawdon BB: The origin of gut and pancreatic neuroendocrine (APUD) cells – the last word? J Pathol 1998;186:117–118.
110.
Andrew A, Kramer B, Rawdon BB: Gut and pancreatic amine precursor uptake and decarboxylation cells are not neural crest derivatives. Gastroenterology 1983;84:429–431.
111.
Fontaine J, Le Douarin NM: Analysis of endoderm formation in the avian blastoderm by the use of quail-chick chimaeras. The problem of the neurectodermal origin of the cells of the APUD series. J Embryol Exp Morphol 1977;41:209–222.
112.
Thompson M, Fleming KA, Evans DJ, Fundele R, Surani MA, Wright NA: Gastric endocrine cells share a clonal origin with other gut cell lineages. Development 1990;110:477–481.
113.
Toni R: The neuroendocrine system: organization and homeostatic role. J Endocrinol Invest 2004;27:35–47.
114.
Odell WD: Paraendocrine syndromes of cancer. Adv Intern Med 1989;34:325–351.
115.
Gould VE, Linnoila RI, Memoli VA, Warren WH: Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest 1983;49:519–537.
116.
Tasiemski A, Salzet M, Benson H, Fricchione GL, Bilfinger TV, Goumon Y, Metz-Boutigue MH, Aunis D, Stefano GB: The presence of antibacterial and opioid peptides in human plasma during coronary artery bypass surgery. J Neuroimmunol 2000;109:228–235.
117.
Suzuki S, Tanaka K, Nagata E, Ito D, Dembo T, Fukuuchi Y: Cerebral neurons express interleukin-6 after transient forebrain ischemia in gerbils. Neurosci Lett 1999;262:117–120.
118.
Reichlin S: Neuroendocrine-immune interactions. N Engl J Med 1993;329:1246–1253.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.